<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vista Pharmaceuticals Limited submitted its annual disclosure to BSE clarifying that it does not fall under the 'Large Corporate' (LC) category as defined under the SEBI circular framework for debt securities issuance. The filing covers FY 2025-26 within a 2-year block period (FY 2025-26 to FY 2026-27). All fields related to incremental borrowing, mandatory borrowing through debt securities, and shortfall amounts show 'Nil' or 'Not Applicable' because the company is not classified as a Large Corporate. No penalties are applicable. The company confirmed it does not meet the applicability criteria under SEBI's 2018 circular on large corporate disclosures.
This is a routine compliance filing with no direct impact on shareholders. The company is simply confirming its non-classification as a Large Corporate, meaning it is not subject to mandatory borrowing norms through debt securities under SEBI regulations.